Erdafitinib to treat urothelial carcinoma
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
|---|---|
| Enthalten in: |
Drugs of today - 55(2019), 8, Seite 495- |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hanna, K.S. [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource |
|---|
| doi: |
10.1358/dot.2019.55.8.3010573 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
KFL001198467 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL001198467 | ||
| 003 | DE-627 | ||
| 005 | 20230623202551.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210608s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1358/dot.2019.55.8.3010573 |2 doi | |
| 035 | |a (DE-627)KFL001198467 | ||
| 035 | |a (KFL)prod_QApH_3010573 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Hanna, K.S. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Erdafitinib to treat urothelial carcinoma |
| 264 | 1 | |c 2019 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 773 | 0 | 8 | |i Enthalten in |t Drugs of today |d [Philadelphia, PA] : Clarivate Analytics, 1998 |g 55(2019), 8, Seite 495- |h Online-Ressource |w (DE-627)KFL000006092 |w (DE-600)2115884-8 |w (DE-576)481527222 |x 1699-4019 |7 nnns |
| 773 | 1 | 8 | |g volume:55 |g year:2019 |g number:8 |g pages:495- |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/thomson-reuters-ejournals-pharmazie/integrity.clarivate.com/integrity/xmlxsl/pk_ref_list.showUniqueReferenceList?p_id=3010573 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-TRE | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 935 | |i IMPORT_0628_prod_QApH_02 | ||
| 951 | |a AR | ||
| 952 | |d 55 |j 2019 |e 8 |h 495- | ||